Clinical Trial Update: Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy plus HAART for AIDS-related primary central nervous system lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Primary Central Nervous System Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-Related-Primary Central Nervous System Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-05-01